A genome-wide association study (GWAS) of overall survival (OS) in 609 metastatic colorectal cancer (mCRC) patients treated with chemotherapy and biologics in CALGB 80405
      Google Scholar   
Citation:
J Clin Oncol vol 33 (suppl) abstr 3599
Meeting Instance:
ASCO 2015
Year:
2015
Type:
Abstract
Sub type:
Poster General
Funding:
NCTN
Endpoint:
Secondary
Analysis:
Primary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
pub
Note:
This study also received support from Bristol-Myers Squibb, Genentech, and Pfizer
Methodological:
No
Biospecimen:
Yes
SDC:
No
Parents:
None
Children:
3326  
Program:
TRP
Primary Committee:
PPP
Sec. Committees:
   
Pharmas:
 
Grants:
U10CA180821, U10CA180882, CA31946  
Corr. Author:
 
Authors:
                             
Networks:
CA011, CA824, LAPS-IL036, LAPS-IL057, LAPS-MA036, LAPS-NC007, OR013   
Study
CALGB-80405
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
3
Keywords: